Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

IBM Forecasts Sales Of Home Furnishings In Q2 Will Be Higher - Quick Facts

RELATED NEWS
Trade IBM now with 
4/6/2012 9:46 AM ET

International Business Machines Corp (IBM: Quote) Friday stated that sales of home furnishings in the second quarter of calendar year 2012 would shoot higher.

Relying on its analytics-based forecast, IBM predicts that in-store sales would increase nearly 8 percent to $23.22 billion and online sales would post an increase of 28.4 percent for the second quarter.

Combined in-store and online sales of home furnishings are expected to grow 16.6 percent in the second quarter, IBM further added.

Click here to receive FREE breaking news email alerts for International Business Machines Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Intel Corp. said Tuesday after the markets closed that its first quarter profit fell 5% from last year, hurt mainly by higher income tax expenses even as revenue grew slightly. The company's quarterly earnings per share came in above analysts' expectations, but its quarterly revenue fell shy of analysts' forecast. With traders digesting a mixed batch of catalysts, stocks saw considerable volatility over the course of the trading day on Tuesday before closing mostly higher. The gains on the day extended the recovery off the two-month lows set last Friday. The major averages showed a notable rebound in afternoon trading to end the day in positive territory. U.S. President Barack Obama and his Russian counterpart Vladimir Putin spoke regarding the ongoing crisis in Ukraine for the first time in over two weeks on Monday, although the two leaders remain far apart on the cause of escalating tensions.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.